Jonathan's practice involves providing commercially-focussed advice on patent origination, patent strategy and portfolio management, licensing and due diligence, prosecuting and defending European patent oppositions, and conducting patent litigation in the UK and Europe.
His practice draws in this variety of experience and extends to a wide range of chemical and pharmaceutical subject matter. Jonathan's practice in the pharmaceutical area has covered both contentious and non-contentious issues and he has provided external consultancy services to a number of large pharmaceutical companies over the last 20 years.
His practice involves providing commercially focused advice to C-suite business leaders, R&D groups, and public institutions on all aspects of patent strategy and portfolio management. This includes obtaining and defending patent rights, providing opinions on freedom to operate where third party intellectual property rights exist, conducting due diligence to support corporate acquisition and licensing deals, challenging third party patent rights and pan-European pharmaceutical litigation.
Jonathan has worked on a number of high profile pharmaceutical matters including working as part of the patent procurement team for Viagra™; prosecution and litigation surrounding Augmentin™, Ritalin™ and Fosrenol™; opposition/appeal work on Zithromax™, Perindopril and Sovaldi™ and due diligence work to support acquisitions (eg New River Pharmaceuticals and Renovo, and IPO's (eg Redx and NuCana plc), and private equity investment funding (eg OriBiotech).
In the non-pharmaceutical area, he has been responsible for filing all of the foundation patents for graphene on behalf of Manchester University's two Nobel Prize winners Geim and Novoselov.
Jonathan's clients include large and small companies, universities and government organisations.
Cert in IP Law Queen Mary, London
C. Chem, FRSC
9th Microbiome R&D and Business Collaboration Forum: Europe will be held on 26th-27th October 2021 in Rotterdam, The Netherlands. The event is dedicated to exploring microbiome research and strategies for …Event details
Medical Technology Ireland Conference will be held on 20-21 October 2021 at the Galway Racecourse. Medical Technology Ireland Conference features presentations by leading international medical device experts with thought-provoking guest …Event details
HGF and Knobbe Martens are holding a webinar on 3rd November. Challenging granted patents: a comparison between Europe and the US In this webinar we will compare and contrast mechanisms …Event details
HGF’s Attorney-At-Law Olivia Petter will be speaking at the WIPR Patents Live Broadcast on Tuesday 26th October. WIPR Patents Live is a programme that gives you access to unmissable live …Event details
IPBC Europe: Leadership Summit will be held in-person on 4-5 October in Dublin. The conference is the top European gathering of senior corporate IP professionals. It will be covering the …Event details
HGF is sponsoring The Business of Science Conference 2021 on 7th October. Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and …Event details
IAM Strategy 300 Global Leaders guide has been published and HGF is delighted to have 4 Partners listed. The guide draws from the worlds of private practice, consulting and other …Read article
HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021. German Biotechnology days is the go to event in the industry and …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.